Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
06/1999
06/15/1999US5912236 Broad-spectrum tumor suppressor genes gene products and methods for tumor suppressor gene therapy
06/15/1999US5912235 Ring-contracted n-demethyl-n-isopropyl-erythromycin-a-spiroacetal compounds, gastrointestinally effective motilin-agonistic properties
06/15/1999US5912228 Mixture with ethylene oxide-propylene oxide block copolymer and ethylenediaminetetraacetic acid
06/15/1999US5912224 Methods and compositions for enhancing cellular response to TGF-β ligands
06/15/1999US5912152 Process for preparing sphingomyelin and ceramide from erythrocyte as a starting material and a curing agent or cosmetic formulated with ceramide
06/15/1999US5912143 Polynucleotides encoding a human mage protein homolog
06/15/1999US5912123 Detection of the leptin receptor in reproductive organs and methods for regulating reproductive biology
06/15/1999US5912013 Drug delivery
06/15/1999US5912011 Solvent system to be enclosed in capsules
06/15/1999US5912010 Prophylactic and therapeutic treatment of skin sensitization and irritation
06/15/1999US5912009 Fatty acid esters of glycolic acid and its salts
06/15/1999US5912008 Laminated structure of backing layer, moisture and impermeable layer, tackifiers and permeation enhancer
06/15/1999US5912007 Delivery system for the localized administration of medicaments to the upper respiratory tract and methods for preparing and using same
06/15/1999US5912006 Analgesics for menstruation pain
06/15/1999US5912005 Methods of use of uncoated gel particles
06/15/1999US5912000 Chitosan induced immunopotentiation
06/15/1999US5911997 Relaxin-like factor and methods and uses thereof
06/15/1999US5911992 Suppress appetite, and also acts to induce thermogenesis and inhibit lipogenesis, so as to prevent weight gain, st. john's wort,
06/15/1999US5911985 Pharmaceutical formulations containing a β-lactamase inhibiting penem in combination with β-lactam antibiotic and their use in the treatment of bacterial infections
06/15/1999US5911970 Antitumor agents and anticarcinogenic agents
06/15/1999CA2191947C Pirydyl imidazole derivatives and processes for the preparation thereof
06/15/1999CA2182477C Pyridyl imidazole derivatives and processes for the preparation thereof
06/15/1999CA2161641C Stable, ingestable and absorbable nadh and nadph therapeutic compositions
06/15/1999CA2159984C Oral compositions for treating plaque and gingivitis containing a noncationic antibacterial agent and a bicarbonate salt
06/15/1999CA2155664C Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents
06/15/1999CA2136821C Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism
06/15/1999CA2128423C Health and beauty aid compositions
06/15/1999CA2119155C Fungicides for the control of take-all disease of plants
06/15/1999CA2087032C Diphenylmethyl piperazine derivatives
06/15/1999CA2055827C Solutions for the perfusion, preservation and reperfusion of organs
06/15/1999CA2001083C Novel s-timolol derivative and process for its preparation
06/10/1999WO1999028475A2 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection
06/10/1999WO1999028469A1 Compositions and methods for inducing gene expression
06/10/1999WO1999028456A1 Splice variants for human 5-ht4 serotonin receptor and their applications, in particular for screening
06/10/1999WO1999028447A1 Human rnase h and compositions and uses thereof
06/10/1999WO1999028440A1 Nucleic acid encoding mammalian ubr1
06/10/1999WO1999028359A1 Preparation for prevention and healing of inflammation affections
06/10/1999WO1999028351A1 Persulfated chondroitin sulfates, process for producing the same, and anticoagulants containing the same as the active ingredient
06/10/1999WO1999028337A1 15-methyl-cyclopropanosteroids and method for the production thereof
06/10/1999WO1999028333A1 Chemical synthesis of 6-o-alkyl erythromycin c
06/10/1999WO1999028332A1 6-o-alkyl erythromycin b oxime
06/10/1999WO1999028325A1 Thienopyrimidines
06/10/1999WO1999028324A1 A process for the reduction of oxiranyl epothilones to olefinic epothilones
06/10/1999WO1999028322A1 Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
06/10/1999WO1999028320A1 2-aryl-8-oxodihydropurine derivatives, process for producing the same, medicinal compositions containing the same, and intermediates thereof
06/10/1999WO1999028318A1 Amino-benzothiazole derivatives
06/10/1999WO1999028317A1 Substituted phenyloxazolidinones and their use as antibiotics
06/10/1999WO1999028316A1 Thiophene-sulfonamide compounds
06/10/1999WO1999028315A1 Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
06/10/1999WO1999028311A1 6-o-alkyl derivatives of erythronolide b
06/10/1999WO1999028310A1 Pseudopolymorphic forms of 2-[2-[4-[bis (4-fluorophenyl) methyl]-1-piperazinyl] ethoxy]acetic acid dihydrochloride
06/10/1999WO1999028309A1 1,3,4-thiadiazoles derivatives as kyn-oh inhibitors
06/10/1999WO1999028306A1 Benzenesulfonamide compounds
06/10/1999WO1999028304A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions
06/10/1999WO1999028300A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors
06/10/1999WO1999027966A1 Minoxidil-containing liquid preparation composition
06/10/1999WO1999027965A1 Antihyperlipemic agents
06/10/1999WO1999027962A1 Use of a fibrinogen receptor-antagonist for preventing disseminated intravascular coagulation
06/10/1999WO1999027943A1 Use of ginkgo biloba extracts for preparing a medicine
06/10/1999WO1999027941A1 Oral antioxidant preparation comprising selenium and reduced glutathione
06/10/1999WO1999027939A1 Ureido derivatives of poly-4-amino-2-carboxy-1-methyl pyrrole compounds for inhibition of inflammation
06/10/1999WO1999027938A1 Method for treating or preventing psychosomatic and psychoimmunologic disorders
06/10/1999WO1999027937A2 Method for inhibiting cytokine production by cells
06/10/1999WO1999027936A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027935A1 Steroid 3-o-sulphamate derivatives as inhibitors of oestrone sulphatase
06/10/1999WO1999027934A1 Endothelin antagonist
06/10/1999WO1999027932A1 Injectable antifungal formulations
06/10/1999WO1999027931A1 USE OF BICOZAMYCIN FOR THE MANUFACTURE OF A MEDICAMENT FOR TREATING INFECTIONS WITH ENTEROHEMORRHAGIC $i(E. COLI)
06/10/1999WO1999027930A1 Thrombin inhibitors
06/10/1999WO1999027927A1 Synergistic antimicrobial compositions
06/10/1999WO1999027926A1 Medicinal use of cromoglycic acid compounds
06/10/1999WO1999027925A1 Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
06/10/1999WO1999027924A2 Fatty acid uninterrupted by a methylene as anti-inflammatory agents in superficial tissues of mammals
06/10/1999WO1999027923A1 Agents for combating neospora spec
06/10/1999WO1999027922A1 The use of polyols in combating yeast infection and polyol preparations for said use
06/10/1999WO1999027921A2 Compositions and methods for modulating the activity of fibroblast growth factor
06/10/1999WO1999027919A2 Cyp2a enzymes and their use in therapeutic and diagnostic methods
06/10/1999WO1999027916A2 Method for producing solid dosing forms
06/10/1999WO1999027914A1 A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane for intramuscular administration
06/10/1999WO1999027913A1 Polyethylene glycol matrix pellets for greasy, oily or sticky drug substances
06/10/1999WO1999027912A1 Porous hydroxyapatite particles as carriers for drug substances
06/10/1999WO1999027911A1 Soft-pellet drug and process for the preparation thereof
06/10/1999WO1999027908A1 Combined chemo-immunotherapy with liposomal drugs and cytokines
06/10/1999WO1999027907A1 Improved method for avoiding the degradation of an active principle
06/10/1999WO1999027906A1 Long acting injectable formulations containing hydrogenated castor oil
06/10/1999WO1999027905A1 Compositions for nasal administration
06/10/1999WO1999027902A1 Composition comprising an amino acid n-undecylenoyl; application in cosmetics
06/10/1999WO1999027899A1 Hair and/or body hygienic product for human beings and animals
06/10/1999WO1999027894A1 Topical anti-acne composition
06/10/1999WO1999027890A2 A process for the preparation of ring-opened epothilone intermediates which are useful for the preparation of epothilone analogs
06/10/1999WO1999027801A1 Revitalisation formulation
06/10/1999WO1999027799A1 Method for producing and using lysine formiate
06/10/1999WO1999027791A1 Zwitterionic fatty acid compounds for anti-inflamation
06/10/1999WO1999027786A1 Control of biofilm formation
06/10/1999WO1999018105A8 Dipyridoimidazolderivatives useful in treating central nervous system disorders
06/10/1999WO1999015535A8 Binuclear complex
06/10/1999WO1999015156B1 Inhibition of crystallization in transdermal devices
06/10/1999WO1999015013A3 Use of quaternary carboxylic acid alkanolamine ester salts as microbicidal agents
06/10/1999WO1999010022A3 Methods and compositions to prevent formation of adhesions in biological tissues
06/10/1999WO1999009964A3 Pharmaceutical composition containing clindamycin and clotrimazol for treating vaginal infections
1 ... 6488 6489 6490 6491 6492 6493 6494 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 6507 6508 ... 7860